Sculptra PLLA — 365 mg | 2 Vials — Galderma
Description
Lenisna was designed as a long-acting filler with a concentration of 170 mg of polylactic acid (PDLLA) and 30 mg of non-crosslinked hyaluronic acid .
By adjusting the amount of solution and the particle size to 50 to 60 micrometers with a round and porous shape, and combining them with non-crosslinked hyaluronic acid, a hybrid suitable for application in subcutaneous or periosteal tissue was obtained. It is intended for the treatment of deep wrinkles, sagging, and significant tissue loss.
Lenisna is one of the most effective collagen production stimulators known in aesthetic medicine, a protein responsible for the hydration, firmness, and elasticity of our skin, directly contributing to its youthful appearance.
Thanks to the combination of polylactic acid (PDLLA) with hyaluronic acid (HA), we obtain a visible effect immediately after treatment.
The filling lasts until the process of producing new collagen by poly D,L lactic acid begins to dominate.